Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Application

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 10
EC Number Application Commentary Reference
Show all pathways known for 2.4.2.26Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.26analysis measurement of fibrosis marker xylosyltransferase I activity by HPLC electrospray ionization tandem mass spectrometry. The simple and robust LC-MS/MS assay permits the rapid and accurate determination of XT-I activity in human serum 679274
Show all pathways known for 2.4.2.26Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.26diagnostics the enzyme is a diagnostic marker of an enhanced proteoglycan biosynthesis 678024
Show all pathways known for 2.4.2.26Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.26medicine monitoring of the seminal plasma for enzyme activity is proposed to be an advantegeous additional biochemical parameter to improve in vitro fertilization methods, because the activity is reduced in seminal plasma of infertile men 637620
Show all pathways known for 2.4.2.26Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.26medicine serum xylosyltransferase activity is a biochemical marker for the assessment of disease activity in systemic sclerosis and for the diagnosis of fibrotic remodeling processes, sequence variations in the XT-I coding gene are identified as risk factors for diabetic nephropathy, osteoarthritis or pseudoxanthoma elasticum 679132
Show all pathways known for 2.4.2.26Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.26medicine serum xylosyltransferase activity is a biochemical marker for the assessment of disease activity in systemic sclerosis and for the diagnosis of fibrotic remodeling processes, sequence variations in the XT-II coding gene are identified as risk factors for diabetic nephropathy, osteoarthritis or pseudoxanthoma elasticum 679132
Show all pathways known for 2.4.2.26Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.26medicine serum xylosyltransferase activity is a biochemical marker for the assessment of disease activity in systemic sclerosis and for the diagnosis of fibrotic remodeling processes. Sequence variations in the XT-I and XT-II coding genes are identified as risk factors for diabetic nephropathy, osteoarthritis or pseudoxanthoma elasticum. Important role of the xylosyltransferases as disease modifiers in pathologies which are characterized by an altered proteoglycan metabolism 679132
Show all pathways known for 2.4.2.26Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.26medicine serum xylosyltransferase I, the novel fibrosis marker, may be useful for the assessment of extracellular matrix alterations and disease activity in Pseudoxanthoma elasticum 681502
Show all pathways known for 2.4.2.26Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.26medicine serum XylT levels may be an informative biomarker in patients who suffer from diseases affecting platelet and/or liver homeostasis 703904
Show all pathways known for 2.4.2.26Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.26medicine ways of modulating the XYLT1 gene expression, especially in the development of therapeutic strategies for the treatment of fibrotic remodeling processes or cartilage repair 704560
Show all pathways known for 2.4.2.26Display the word mapDisplay the reaction diagram Show all sequences 2.4.2.26medicine xylosyltransferase I is a fibrosis marker 679274
Results 1 - 10 of 10